6-Shogaol inhibited IL-1β secretion by blocking NLRP3 inflammasome activation and reduced TNF-α levels, demonstrating a relevant anti-inflammatory effect in the context of obesity. This evidence concerns the gene TNF and obesity due to melanocortin 4 receptor deficiency.